Beam Therapeutics, Inc. (BEAM)
22.85
-1.18
(-4.91%)
USD |
NASDAQ |
Nov 13, 16:00
22.99
+0.14
(+0.61%)
After-Hours: 19:59
Beam Therapeutics Price to Book Value : 2.481 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 2.609 |
| November 11, 2026 | 2.802 |
| November 10, 2026 | 2.731 |
| November 09, 2026 | 2.934 |
| November 06, 2026 | 2.868 |
| November 05, 2026 | 2.809 |
| November 04, 2026 | 3.018 |
| November 03, 2026 | 2.859 |
| November 02, 2026 | 2.809 |
| October 30, 2026 | 2.957 |
| October 29, 2026 | 3.132 |
| October 28, 2026 | 3.125 |
| October 27, 2026 | 2.704 |
| October 26, 2026 | 2.583 |
| October 23, 2026 | 2.611 |
| October 22, 2026 | 2.667 |
| October 21, 2026 | 2.697 |
| October 20, 2026 | 2.707 |
| October 19, 2026 | 2.627 |
| October 16, 2026 | 2.548 |
| October 15, 2026 | 2.685 |
| October 14, 2026 | 2.568 |
| October 13, 2026 | 2.653 |
| October 12, 2026 | 2.729 |
| October 09, 2026 | 2.791 |
| Date | Value |
|---|---|
| October 08, 2026 | 2.671 |
| October 07, 2026 | 2.690 |
| October 06, 2026 | 2.740 |
| October 05, 2026 | 2.787 |
| October 02, 2026 | 2.660 |
| October 01, 2026 | 2.648 |
| September 30, 2026 | 2.655 |
| September 29, 2026 | 2.372 |
| September 28, 2026 | 2.344 |
| September 25, 2026 | 2.348 |
| September 24, 2026 | 2.386 |
| September 23, 2026 | 2.358 |
| September 22, 2026 | 2.508 |
| September 21, 2026 | 2.444 |
| September 18, 2026 | 2.414 |
| September 17, 2026 | 2.387 |
| September 16, 2026 | 2.235 |
| September 15, 2026 | 2.246 |
| September 14, 2026 | 2.333 |
| September 11, 2026 | 2.321 |
| September 10, 2026 | 2.358 |
| September 09, 2026 | 2.435 |
| September 08, 2026 | 2.596 |
| September 04, 2026 | 2.869 |
| September 03, 2026 | 2.85 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Intellia Therapeutics, Inc. | 2.220 |
| Twist Bioscience Corp. | 15.69 |
| Prime Medicine, Inc. | 19.32 |
| Sarepta Therapeutics, Inc. | 1.126 |
| Q32 Bio, Inc. | 0.9061 |
Price to Book Value Related Metrics
| PS Ratio | 16.25 |
| Price | 22.85 |
| Earnings Yield | -4.57% |
| Market Cap | 2.364B |